Amedisys Inc
NASDAQ:AMED
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Amedisys Inc
Amedisys Inc
Other Liabilities
Amedisys Inc
Other Liabilities Peer Comparison
DVA
DGX
CVS
CI
LH
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amedisys Inc
NASDAQ:AMED
|
Other Liabilities
$63m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
0%
|
CAGR 10-Years
20%
|
|
|
DaVita Inc
NYSE:DVA
|
Other Liabilities
$2.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
20%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Other Liabilities
$1.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
8%
|
|
|
CVS Health Corp
NYSE:CVS
|
Other Liabilities
$30.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
35%
|
|
|
Cigna Corp
NYSE:CI
|
Other Liabilities
$21.7B
|
CAGR 3-Years
76%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Other Liabilities
$1.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
See Also
What is Amedisys Inc's Other Liabilities?
Other Liabilities
63m
USD
Based on the financial report for Mar 31, 2024, Amedisys Inc's Other Liabilities amounts to 63m USD.
What is Amedisys Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
20%
Over the last year, the Other Liabilities growth was -2%. The average annual Other Liabilities growth rates for Amedisys Inc have been -13% over the past three years , and 20% over the past ten years .
You don't have any saved screeners yet
